Influence of size and surface roughness of large lactose carrier particles in dry powder inhaler formulations

被引:101
作者
Donovan, Martin J. [1 ]
Smyth, Hugh D. C. [1 ]
机构
[1] Univ Texas Austin, Coll Pharm, Div Pharmaceut, Austin, TX 78712 USA
关键词
Binary formulations; Lactose; Carrier particles; Surface roughness; Dry powder inhalers; AEROSOLIZED SALBUTAMOL SULFATE; CLASSIFIER TECHNOLOGY ACT; INTERACTIVE MIXTURES; ADHESIVE MIXTURES; IN-VITRO; AIR CLASSIFIER; DRUG PARTICLES; INHALATION; DEPOSITION; FORCE;
D O I
10.1016/j.ijpharm.2010.08.045
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The objective of this study was to determine the effect of both carrier particle size and surface roughness on the aerosol performance of dry powder formulations. Two morphologically distinct grades of lactose, anhydrous (AN) and granulated (GR), were fractionated into 11 discreet sizes up to 300 mu m, and separately employed as carriers in 2% (w/w) budesonide blends. In vitro deposition studies were performed at 60 L min(-1) with an Aerolizer (R) DPI. It was found that large carriers can improve dispersion performance, although the effect is more pronounced with greater surface roughness. AN carriers exhibited minimal surface roughness and generally behaved as predicted from the literature, with the smaller carriers outperforming their larger counterparts. In contrast, GR carriers had a high degree of surface roughness, and the dispersion performance of larger carriers exceeded that of the smaller size fractions. Comparing the two lactose grades, AN carriers deposited a greater fraction of the total dose up to the 90-125 mu m size range, when they were surpassed in performance by the GR carriers. These results suggest that the mechanism of drug detachment varies with the physical properties of the carrier particle population, where surface roughness can alter the predominant detachment mechanism to favor larger carrier particle diameters. Published by Elsevier B.V.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 30 条
  • [11] Hickey A.J., 2004, PHARM INHALATION AER
  • [12] Physical characterization of component particles included in dry powder inhalers. I. Strategy review and static characteristics
    Hickey, Anthony J.
    Mansour, Heidi M.
    Telko, Martin J.
    Xu, Zhen
    Smyth, Hugh D. C.
    Mulder, Tako
    McLean, Richard
    Langridge, John
    Papadopoulos, Dimitris
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2007, 96 (05) : 1282 - 1301
  • [13] Predicting the behavior of novel sugar carriers for dry powder inhaler formulations via the use of a cohesive-adhesive force balance approach
    Hooton, Jennifer C.
    Jones, Matthew D.
    Price, Robert
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 95 (06) : 1288 - 1297
  • [14] Lactose surface modification by decantation: Are drug-fine lactose ratios the key to better dispersion of salmeterol xinafoate from lactose-interactive mixtures?
    Islam, N
    Stewart, P
    Larson, I
    Hartley, P
    [J]. PHARMACEUTICAL RESEARCH, 2004, 21 (03) : 492 - 499
  • [15] Pulmonary deposition of lactose carriers used in inhalation powders
    Karhu, M
    Kuikka, J
    Kauppinen, T
    Bergström, K
    Vidgren, M
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 196 (01) : 95 - 103
  • [16] Effect of surface morphology of carrier lactose on dry powder inhalation property of pranlukast hydrate
    Kawashima, Y
    Serigano, T
    Hino, T
    Yamamoto, H
    Takeuchi, H
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1998, 172 (1-2) : 179 - 188
  • [17] The use of different grades of lactose as a carrier for aerosolised salbutamol sulphate
    Larhrib, H
    Zeng, XM
    Martin, GP
    Marriott, C
    Pritchard, J
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 191 (01) : 1 - 14
  • [18] Influence of physico-chemical carrier properties on the in vitro aerosol deposition from interactive mixtures
    Louey, MD
    Razia, S
    Stewart, PJ
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 252 (1-2) : 87 - 98
  • [19] Particle interactions involved in aerosol dispersion of ternary interactive mixtures
    Louey, MD
    Stewart, PJ
    [J]. PHARMACEUTICAL RESEARCH, 2002, 19 (10) : 1524 - 1531
  • [20] Protein deposition from dry powder inhalers: Fine particle multiplets as performance modifiers
    Lucas, P
    Anderson, K
    Staniforth, JN
    [J]. PHARMACEUTICAL RESEARCH, 1998, 15 (04) : 562 - 569